loadpatents
name:-0.0034589767456055
name:-0.012953996658325
name:-0.00046706199645996
James Black Foundation Limited Patent Filings

James Black Foundation Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for James Black Foundation Limited.The latest application filed is for "benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands".

Company Profile
0.10.2
  • James Black Foundation Limited - 68 half Moon Lane, Dulwich London GB
  • The James Black Foundation Limited - London GB
  • James Black Foundation Limited - Dulwich GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
App 20070082892 - Spencer; John ;   et al.
2007-04-12
Gastrin and cholecystokinin receptor lignads (iv)
Grant 7,105,558 - Linney , et al. September 12, 2
2006-09-12
Gastrin and cholecystokinin receptor ligands (III)
Grant 7,034,048 - Kalindjian , et al. April 25, 2
2006-04-25
Benzotriazepnes as gastrin and cholecystokinin receptor ligands
App 20060003993 - McDonald; Iain Mair ;   et al.
2006-01-05
Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands
Grant 6,956,053 - McDonald , et al. October 18, 2
2005-10-18
Histamine H3 receptor ligands
Grant 6,878,736 - Kalindjian , et al. April 12, 2
2005-04-12
Gastrin and cholecystokinin receptor ligands(II)
Grant 6,878,734 - Kalindjian , et al. April 12, 2
2005-04-12
Gastrin and cholecystokinin receptor ligands
Grant 6,479,531 - Kalindjian , et al. November 12, 2
2002-11-12
Sulfonamides and sulfamides as H.sub.3 receptor antagonists
Grant 6,080,871 - Kalindjian , et al. June 27, 2
2000-06-27
Gastrin and cck receptor ligands
Grant 5,919,829 - Kalindjian , et al. July 6, 1
1999-07-06
Gastrin and CCK antagonists
Grant 5,912,260 - Kalindjian , et al. June 15, 1
1999-06-15
Tetrapeptide derivatives and analogues
Grant 5,486,597 - Kalindjian , et al. January 23, 1
1996-01-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed